Get the Stockscreener App
2.495
1.96%
-0.055
Tuhura Biosciences Inc stock is traded at $2.495, with a volume of 35,905.
It is down -1.96% in the last 24 hours and down -3.85% over the past month.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
See More
Previous Close:
$2.55
Open:
$2.52
24h Volume:
35,905
Relative Volume:
0.09
Market Cap:
$130.31M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.70%
1M Performance:
-3.85%
6M Performance:
-36.22%
1Y Performance:
-58.95%
1-Day Range:
$2.475
$2.535
1-Week Range:
$2.25
$2.56
52-Week Range:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Name
Tuhura Biosciences Inc
Sector
Industry
Phone
813-875-6600
Address
10500 UNIVERSITY CENTER DR., TAMPA
Compare HURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
2.495 | 130.31M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.44 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.71 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.56 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.88 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-03-25 | Initiated | H.C. Wainwright | Buy |
| Dec-19-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-05-24 | Initiated | Maxim Group | Buy |
Tuhura Biosciences Inc Stock (HURA) Latest News
Applying Wyckoff theory to TuHURA Biosciences Inc. stockSwing Trade & Community Consensus Picks - newser.com
How to integrate TuHURA Biosciences Inc. into portfolio analysis toolsEarnings Miss & Real-Time Volume Triggers - newser.com
What moving averages say about TuHURA Biosciences Inc.Bull Run & Fast Exit/Entry Strategy Plans - newser.com
How TuHURA Biosciences Inc. (PL3) stock valuation compares with sectorWeekly Market Outlook & Low Volatility Stock Recommendations - newser.com
TuHURA Biosciences Inc. stock volume spike explainedWeekly Gains Summary & Technical Entry and Exit Tips - newser.com
What earnings revisions data tells us about TuHURA Biosciences Inc.Portfolio Update Report & Weekly Setup with High ROI Potential - newser.com
How TuHURA Biosciences Inc. stock benefits from strong dollarRecession Risk & AI Based Buy and Sell Signals - newser.com
Can machine learning forecast TuHURA Biosciences Inc. recovery2025 Growth vs Value & Weekly Market Pulse Updates - newser.com
Is TuHURA Biosciences Inc. stock gaining market shareJuly 2025 EndofMonth & Precise Swing Trade Entry Alerts - newser.com
Can TuHURA Biosciences Inc. (PL3) stock retain market dominance2025 Volume Leaders & Verified Entry Point Signals - newser.com
Will TuHURA Biosciences Inc. bounce back from current supportOil Prices & Weekly Top Gainers Trade List - newser.com
Multi asset correlation models including TuHURA Biosciences Inc.Rate Cut & Low Risk Growth Stock Ideas - newser.com
Is TuHURA Biosciences Inc. stock a safe investment in uncertain marketsMarket Performance Recap & Daily Technical Stock Forecast Reports - newser.com
Why analysts raise outlook for TuHURA Biosciences Inc. (PL3) stock - newser.com
Using Ichimoku Cloud for TuHURA Biosciences Inc. technicals2025 Year in Review & Short-Term Trading Opportunity Alerts - newser.com
TuHURA Biosciences Secures $3M Bridge Loan Agreement - TipRanks
Is TuHURA Biosciences Inc. stock in correction or buying zoneJuly 2025 Recap & Entry Point Confirmation Signals - newser.com
Will TuHURA Biosciences Inc. rebound enough to break even2025 Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
Can technical indicators confirm TuHURA Biosciences Inc.’s reversal2025 Historical Comparison & Weekly Top Gainers Trade List - newser.com
Will TuHURA Biosciences Inc. (PL3) stock deliver compounding returnsJuly 2025 Setups & Fast Entry Momentum Trade Alerts - newser.com
Will TuHURA Biosciences Inc. (PL3) stock hit analyst forecasts2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Will TuHURA Biosciences Inc. (PL3) stock draw ESG focused fundsQuarterly Trade Summary & Risk Managed Investment Entry Signals - newser.com
What the Technical Charts Reveal About Nibe Limiteds MomentumDay Trading Setups & Free Tap Rapid Wealth - earlytimes.in
News impact scoring models applied to TuHURA Biosciences Inc.Bear Alert & Weekly High Potential Stock Alerts - newser.com
Tuhura Biosciences Inc Stock (HURA) Financials Data
There is no financial data for Tuhura Biosciences Inc (HURA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):